Predictors of Enrollment into a Familial Cancer Registry by Individuals at High Risk for BRCA1/2
暂无分享,去创建一个
[1] D. Bowen,et al. Predictors of Self-Referral into a Cancer Genetics Registry , 2007, Cancer Epidemiology Biomarkers & Prevention.
[2] H. Lynch,et al. Brain tumors in individuals with familial adenomatous polyposis , 2007, Cancer.
[3] V. Venne,et al. Colorectal Cancer Surveillance Behaviors Among Members of Typical and Attenuated FAP Families , 2007, The American Journal of Gastroenterology.
[4] C. Isaacs,et al. Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors , 2006, Breast Cancer Research and Treatment.
[5] James S. Evans,et al. Factors Associated with Enrollment in Cancer Genetics Research , 2006, Cancer Epidemiology Biomarkers & Prevention.
[6] D. Bowen,et al. Analysis of Co-Aggregation of Cancer Based on Registry Data , 2006, Public Health Genomics.
[7] P. Salkovskis,et al. Applying a cognitive behavioral model of health anxiety in a cancer genetics service. , 2006, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[8] Shing M. Lee,et al. Active recruitment increased enrollment in a hereditary cancer registry. , 2004, Journal of clinical epidemiology.
[9] C. Skinner,et al. Racial differences in enrolment in a cancer genetics registry. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[10] P. McDonald,et al. Minority recruitment in hereditary breast cancer research. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[11] Prakash Nadkarni,et al. The Cancer Genetics Network: Recruitment Results and Pilot Studies , 2003, Public Health Genomics.
[12] C. Hughes,et al. Sociocultural influences on participation in genetic risk assessment and testing among African American women. , 2003, Patient education and counseling.
[13] Susan L Neuhausen,et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. , 2002, The New England journal of medicine.
[14] C. Isaacs,et al. All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. , 2002, American journal of medical genetics.
[15] W. Lawrence,et al. Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[16] K. Heimdal,et al. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study , 2000, The Lancet.
[17] O. Olopade,et al. Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] D. Easton,et al. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. , 1993, American journal of human genetics.
[19] L. Derogatis,et al. The Brief Symptom Inventory: an introductory report , 1983, Psychological Medicine.
[20] M. Horowitz,et al. Impact of Event Scale: A Measure of Subjective Stress , 1979, Psychosomatic medicine.
[21] D. Easton,et al. Genetic Linkage Analysis in Familial Breast and Ovarian Cancer: Results from 214 Families , 2006 .
[22] C. Isaacs,et al. Breast and Ovarian Cancer Screening Practices in Healthy Women with a Strong Family History of Breast or Ovarian Cancer , 2004, Breast Cancer Research and Treatment.
[23] N. Boyd,et al. Characteristics associated with participation at various stages at the Ontario site of the cooperative family registry for breast cancer studies. , 2002, Annals of epidemiology.
[24] K. Cox. Informed consent and decision-making: patients' experiences of the process of recruitment to phases I and II anti-cancer drug trials. , 2002, Patient education and counseling.